New serine protease inhibitors with leukotriene B4 (LTB4) receptor binding affinity

Bioorganic and Medicinal Chemistry

Volumn 5, Issue 5, 1997, Pages 971-985

  Nakayama, Yoshisuke ^a   Senokuchi, Kazuhiko ^a   Sakaki, Katsuhito ^a   Kato, Masashi ^a   Maruyama, Toru ^a   Miyazaki, Toru ^a   Ito, Hidenori ^a   Nakai, Hisao ^a   Kawamura, Masanori ^a  

^a ONO PHARMACEUTICAL CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOTRIENE B4; LEUKOTRIENE B4 RECEPTOR; LEUKOTRIENE B4 RECEPTOR ANTAGONIST; SERINE PROTEINASE INHIBITOR;

ARTICLE; CALCIUM MOBILIZATION; DRUG ACTIVITY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; NEUTROPHIL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTEINASE INHIBITION; RECEPTOR AFFINITY;

AMIDINES; CALCIUM; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; HUMANS; LEUKOTRIENE B4; NEUTROPHILS; RECEPTORS, LEUKOTRIENE B4; SERINE PROTEINASE INHIBITORS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0031008607     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(97)00036-9     Document Type: Article

References (17)

1. Morrissey, M. M. Japan Kokai Tokkyo Koho, 1993, 5-239009.
2. Testa, B; Kyburz, E; Fuhrer, W; Giger, R., Ed. Perspectives in Medicinal Chemistry; Verlag Helvetica Chimica Acta: Basel, 1993; p 27.
3. Ku, T. W.; Ali, F. E.; Barton, L. S.; Bean, J. W.; Bondinell, W. E.; Burgess, J. L.; Callahan, J. F.; Calvo, R. R.; Chen, L.; Eggleston, D. S.; Gleason, J. G.; Huffman, W. F.; Hwang, S. M.; Jakas, D. R.; Karash, C. B.; Keenan, P. M.; Kopple, K. D.; Miller, W. H.; Newlander, K. A.; Nichols, A.; Parker, M. F.; Peishoff, C. E.; Samanen, J. M.; Uzinskas, I.; Venslavsky, J. W., J. Am. Chem. Soc., 1993, 115, 8861.
4. Moore, W. M.; Webber, R. K.; Fok, K. F.; Jerome, G. M.; Connor, J. R.; Manning, P. T.; Wyatt P. S.; Misko, T. P.; Tjoeng, F. S.; Currie, M. G., J. Med. Chem., 1996, 39, 669.
5. Senokuchi, K.; Nakai, H.; Nakayama, Y.; Odagaki, Y.; Sakaki, K.; Kato, M.; Maruyama, T.; Miyazaki, T.; Ito, H.; Kamiyasu, K.; Kim, S.; Kawamura, M.; Hamanaka, N., J. Med. Chem., 1995, 38, 2521.
6. Senokuchi, K.; Nakai, H.; Nakayama, Y.; Odagaki, Y.; Sakaki, K.; Kato, M.; Maruyama, T.; Miyazaki, T.; Ito, H.; Kamiyasu, K.; Kim, S.; Kawamura, M.; Hamanaka, N., J. Med. Chem., 1995, 38, 4508.
7. (a) Kishikawa, K.; Nakao, S.; Matsumoto, S.; Kondo, K.; Hamanaka, N., Adv. in Prostaglandin, Thromboxane, and Leukotriene Research, 1995, 23, 279.
8. 4 antagonists based on the results obtained in 1 and 2.
9. (a) Nii, Y.; Okano, K.; Kobayashi, S.; Ohno, M., Tetrahedron Lett., 1979, 27, 2517.
10. (b) A single isomer was obtained. As far as its stereochemistry (syn or anti) is concerned, exact structural determination using X-ray crystallographic analysis is in progress in our laboratory.
11. Sakurai, Y.; Nakayama, T.; Yaegashi, T.; Nunomura, S.; Okutome, T. Japan Kokai Tokkyo Koho, 1983, 58-41855.
12. Compounds 45a-c were prepared by the usual procedure. equation presented (1) DCC, pyridine, 25 °C, 24 h; (2) TFA, anisole, 2 h.
13. (a) Wikel, J. H.; Sofia, M. J.; Saussy, Jr., D. L.; Bemis, K. G., Bioorg. Med. Chem. Lett., 1994, 4, 795.
14. (b) Daines, R. A.; Chambers, P. A.; Eggleston, D. S.; Foley, J. J.; Griswold, D. E.; Haltiwanger, R. C.; Jakas, D. R.; Kingsbury, W. D.; Martin, L. D.; Pendrak. I.; Schmidt, D. B.; Tzimas, M. N.; Sarau, H. M., J. Med. Chem., 1994, 37, 3327.
15. (c) Penning, T. D.; Djuric, S. W.; Miyashiro, J. M.; Yu, S.; Snyder, J. P.; Spangler, D.; Anglin, C. P.; Fretland, D. J.; Kachur, J. F.; Keith, R. H.; Tsai, B. S.; Villani-Price, D.; Walsh, R. E.; Widomski, D. L., J. Med. Chem., 1995, 38, 858.
16. 5,6 for 1 and 2 because they contain a common amidinophenyl function as a potency-and spectrum -determining function.
17. All of the amidine derivatives and the guanidine derivatives were isolated and evaluated as their methanesulfonates.